Fennec Pharmaceuticals Inc. FENC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

54/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Fennec Pharmaceuticals Inc. (FENC), dont 34 achats et 16 ventes. Le total des achats d'initiés s'élève à $280.29K et le total des ventes d'initiés à $11.01M.

Les initiés notables ayant une activité récente comprennent Raykov Rosty, Andrade Robert, Hackman Jeffrey S.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — FENC

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Raykov Rosty	Director	Vente Informative	10,946	$6.31	$69.07K	113,856
2026-03-31	Andrade Robert	Chief Financial Officer	Exercice d'Options	14,724	-	-	271,380
2026-03-31	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	109,204
2026-03-31	Hackman Jeffrey S.	Chief Executive Officer	Exercice d'Options	16,695	-	-	45,405
2026-03-31	Evans Terry L	Chief Commercial Officer	Exercice d'Options	18,456	-	-	18,456
2026-03-31	Sayad Pierre Sargis	Chief Medical Officer	Exercice d'Options	18,456	-	-	18,456
2026-03-31	Cioffi Christiana Marie	Chief Strategy Officer	Exercice d'Options	17,106	-	-	21,806
2026-03-28	Andrade Robert	Chief Financial Officer	Exercice d'Options	12,270	-	-	285,863
2026-03-28	Hackman Jeffrey S.	Chief Executive Officer	Exercice d'Options	13,943	-	-	60,507
2026-03-28	Evans Terry L	Chief Commercial Officer	Exercice d'Options	2,052	-	-	20,679
2026-03-28	Sayad Pierre Sargis	Chief Medical Officer	Exercice d'Options	2,052	-	-	20,679
2026-03-28	Cioffi Christiana Marie	Chief Strategy Officer	Exercice d'Options	1,901	-	-	23,865
2026-03-26	Andrade Robert	Chief Financial Officer	Exercice d'Options	13,072	$5.10	$66.67K	256,656
2026-03-26	Cioffi Christiana Marie	Chief Strategy Officer	Exercice d'Options	4,700	$4.23	$19.88K	4,700
2026-03-02	Raykov Rosty	Director	Vente Informative	10,079	$8.36	$84.26K	103,996
2026-02-28	Andrade Robert	Chief Financial Officer	Attribution de RSU	1,191	-	-	243,584
2026-02-28	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	109,204
2026-02-18	Andrade Robert	Chief Financial Officer	Exercice d'Options	2,450	$4.08	$10K	215,108
2026-02-18	Hackman Jeffrey S.	Chief Executive Officer	Exercice d'Options	13,710	-	-	28,710
2026-02-02	Raykov Rosty	Director	Vente Informative	10,349	$7.76	$80.31K	98,477
2026-01-31	Andrade Robert	Chief Financial Officer	Attribution de RSU	1,558	-	-	212,658
2026-01-31	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	93,228
2026-01-23	Andrade Robert	Chief Financial Officer	Exercice d'Options	10,000	$2.45	$24.5K	211,100
2026-01-15	Andrade Robert	Chief Financial Officer	Exercice d'Options	10,000	$2.45	$24.5K	201,100
2026-01-07	Andrade Robert	Chief Financial Officer	Exercice d'Options	14,184	$2.45	$34.75K	191,100
2026-01-02	Raykov Rosty	Director	Vente Informative	10,312	$7.60	$78.37K	88,020
2025-12-31	Andrade Robert	Chief Financial Officer	Attribution de RSU	1,382	-	-	176,916
2025-12-31	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	82,734
2025-12-24	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	1,000,000	$7.50	$7.5M	2,744,741
2025-12-05	Raykov Rosty	Director	Vente Informative	10,000	$7.54	$75.4K	77,526
2025-12-01	Andrade Robert	Chief Financial Officer	Attribution de RSU	2,430	-	-	175,534
2025-12-01	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	87,526
2025-11-18	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	19,341	$8.79	$170.05K	3,744,741
2025-11-17	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	85,918	$8.79	$755.19K	3,764,082
2025-11-14	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	160,100	$8.00	$1.28M	3,850,000
2025-11-05	Raykov Rosty	Director	Vente Informative	10,000	$8.10	$81K	82,318
2025-10-31	Andrade Robert	Chief Financial Officer	Attribution de RSU	2,430	-	-	173,104
2025-10-31	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	92,318
2025-10-10	Rallis Chris A	Director	Vente Informative	1,775	$9.24	$16.4K	57,079
2025-10-09	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	20,609	$9.35	$192.61K	4,010,100
2025-10-08	Raykov Rosty	Director	Exercice d'Options	4,609	$2.45	$11.29K	87,110
2025-10-08	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	19,605	$9.47	$185.72K	4,030,709
2025-10-07	Southpoint Capital Advisors Lp	10 Percent Owner	Vente Informative	26,900	$9.59	$257.89K	4,050,314
2025-10-06	Raykov Rosty	Director	Vente Informative	10,000	$9.78	$97.8K	82,501
2025-09-30	Andrade Robert	Chief Financial Officer	Attribution de RSU	2,430	-	-	170,674
2025-09-30	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	92,501
2025-09-05	Raykov Rosty	Director	Exercice d'Options	36,207	$2.45	$88.71K	87,293
2025-09-04	Raykov Rosty	Director	Vente Informative	10,000	$8.92	$89.2K	51,086
2025-08-31	Andrade Robert	Chief Financial Officer	Attribution de RSU	2,431	-	-	168,244
2025-08-31	Raykov Rosty	Director	Attribution de RSU	5,208	-	-	61,086

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration